LACUTAMAB

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Approval Year

Substance Class	Protein
Protein Type	MONOCLONAL ANTIBODY
Protein Sub Type	IGG1
Sequence Origin	HUMANIZED MOUSE
Sequence Type	COMPLETE
Record UNII	N8O7MY0VNS
Record Status	`Validated (UNII)`
Record Version

Show entries

Name

Type

Language

LACUTAMAB

Official Name

English

IPH4102

Code

English

IMMUNOGLOBULIN G1(240-ASPARTIC ACID, 333-GLUTAMIC ACID), ANTI-(HUMAN KILLER CELL IMMUNOGLOBULIN-LIKE RECEPTOR KIR3DL2) (HUMAN-MUS MUSCULUS MONOCLONAL IPH4102 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL IPH4102 .KAPPA.-CHAIN, DIMER

Systematic Name

English

IPH-4102

Code

English

lacutamab [INN]

Common Name

English

Showing 1 to 5 of 6 entries

Previous1 2Next

Show entries

Classification Tree

Code System

Code

Biological Agent

NCI_THESAURUS

C20401

Designated

FDA ORPHAN DRUG

574717

Antineoplastic Biological Agent

NCI_THESAURUS

C129822

Positive

EU-Orphan Drug

EU/3/14/1322

Showing 1 to 4 of 4 entries

Show entries

Code System

Code

Type

Description

INN

10924

PRIMARY

NCI_THESAURUS

C124999

PRIMARY

FDA UNII

N8O7MY0VNS

PRIMARY

CAS

2187368-16-5

PRIMARY

DRUG BANK

DB15322

PRIMARY

Showing 1 to 5 of 5 entries

Subunit 0

Subunit 1

Subunit 2

Subunit 3

Show entries

From	To
1_22	1_96
1_145	1_201
1_221	3_214
1_227	2_227
1_230	2_230

Showing 1 to 5 of 16 entries

Previous1 2 3 4Next

Glycosylation Type

MAMMALIAN

Show entries

Showing 1 to 2 of 2 entries

Show entries

Related Record

Type

Details


					N8O7MY0VNS

LACUTAMAB

ACTIVE MOIETY

Amount:

Showing 1 to 1 of 1 entries

Show entries

Name	Property Type	Amount	Referenced Substance	Defining	Parameters	References
MOL_WEIGHT:NUMBER(CALCULATED)	CHEMICAL	ESTIMATED 145000 Da (average)
Molecular Formula	CHEMICAL	ESTIMATED C6428H9904N1706O2014S44

Showing 1 to 2 of 2 entries